Merck to present new data at ACTRIMS-ECTRIMS MSVirtual2020 meeting, promoting innovation in multiple sclerosis
Not intended for media in the UK and USA: the company will provide 54 abstracts in its portfolio MS – MAVENCLAD® (cladribine tablets), Rebif® (interferoArray . .